Authors:
Kiran Pulidindi, Kavita Yadav
Download free PDF
Chloromethane Market Size & Share 2026-2035
Report ID: GMI9994
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Chloromethane Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Chloromethane Market Size
The chloromethane market was valued at USD 4.50 billion in 2025, is expected to reach USD 4.70 billion in 2026, and is projected to grow at a 4.5% CAGR (2026-2035) to USD 7.00 billion by 2035. The market covers demand-side revenue for methyl chloride, methylene chloride (DCM), chloroform, carbon tetrachloride, and related commercial grades used across industrial, pharmaceutical, agrochemical, and refrigerant value chains.
Chloromethane Market Key Takeaways
Market Leader: Olin Corporation led with over 14.70% market share in 2025.
Leading Players: Top 5 players in this market include Olin Corporation, OxyChem (Occidental Chemical Corporation), Shin-Etsu Chemical Co., Ltd., INEOS Inovyn, Gujarat Alkalies and Chemicals Limited (GACL), which collectively held a market share of 57.30% in 2025.
Growth is being reshaped by silicone supply-chain investment, lower-global-warming-potential refrigerant transitions, and Asian active pharmaceutical ingredient manufacturing. These demand channels are offset by tighter solvent-use regulation for DCM and the managed decline of HCFC-22 production, making application mix and regulatory exposure more consequential than broad commodity demand alone.
GMI Analyst View
Based on input from industry leaders, global chloromethane demand volume reached approximately 4.4 million metric tons in 2025. We view this physical demand base as evidence of the market's industrial depth: integrated feedstock and processing uses can sustain offtake even when revenue is affected by commodity-price cycles.
Chloromethane Market Trends, Growth Drivers & GMI Forecast Outlook
The forecast is supported by an increasingly differentiated demand mix. Refrigerant feedstocks and silicones provide scale, while pharmaceutical-grade solvent uses add resilience; conversely, restrictions on industrial DCM uses and European cost pressure narrow several legacy demand and supply positions.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
HFO and HCFO capacity additions change the role of carbon tetrachloride from a legacy ozone-depleting substance to a controlled feedstock input. This demand channel partly cushions the loss of chloroform consumption tied to HCFC-22, provided new refrigerant capacity continues to absorb feedstock volumes in China, India, and the United States.
Methyl chloride demand is closely linked to the chlorosilane route used for silicone production. Electronics encapsulation, electric-vehicle thermal management, and infrastructure applications support downstream silicone requirements, although upstream siloxane overcapacity can weaken the conversion of volume growth into chloromethane revenue.
Pharmaceutical processing remains comparatively insulated because process validation, impurity controls, and extraction performance limit immediate substitution. That protection does not eliminate longer-term green-solvent risk, but it supports a more durable demand corridor than broad industrial solvent uses.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The U.S. EPA's methylene chloride rule removes major consumer and commercial solvent uses under a phased schedule while maintaining controlled exemptions for pharmaceutical manufacturing and selected specialized applications [7]US Environmental Protection Agency. "Risk Management for Methylene Chloride." epa.gov. The effect is a structural reduction in the addressable DCM solvent pool rather than a short-term cyclical slowdown.
European producers face a separate constraint: energy, carbon, and compliance costs impair reinvestment economics and favor lower-cost supply centers. INEOS Inovyn's Tavaux decision demonstrates how these pressures can translate into capacity rationalization rather than merely lower margins [4]INEOS Inovyn. "INEOS Inovyn Announces the Mothballing of Its Chloromethane Production Facility in Tavaux, France." ineos.com.
GMI Analyst View
We see the forecast as a contest between expanding HFO feedstock demand and contracting legacy solvent and HCFC-linked uses. The market's outcome will depend on whether specialized applications, particularly silicone and regulated pharmaceutical processing, continue to absorb the demand displaced by regulatory change.
Chloromethane Market Segment Analysis
By Product
The chloromethane market is anchored by product streams with fundamentally different exposure to silicone production, pharmaceutical processing, and refrigerant transitions.
Methyl Chloride (CH3Cl). Methyl chloride accounted for 32% of revenue in 2025 and is projected to reach USD 2.31 billion by 2035. Its position reflects its role as a chlorosilane feedstock, tying demand to integrated silicone capacity and downstream electronics, mobility, and construction applications.
Methylene Chloride / DCM (CH2Cl2). DCM generated USD 1.03 billion in 2025 and is forecast to grow at a 4.05% CAGR (2026-2035). Pharmaceutical-grade consumption moderates the impact of restrictions on conventional cleaning, stripping, and adhesive uses, leaving the product's outlook dependent on its specialty-process mix.
Chloroform / Trichloromethane (CHCl3). Chloroform represented 38% of revenue in 2025 and is projected to reach USD 2.73 billion by 2035. Demand is pulled in opposing directions by declining HCFC-22 production and increasing needs in pharmaceutical chemistry and fluorochemical process chains.
Carbon Tetrachloride (CCl4). Carbon tetrachloride was valued at USD 180 million in 2025 and is projected to hold a 3% share by 2035. Its commercial scope is largely restricted to controlled feedstock uses, leaving HFO-related production the principal source of demand support.
Others. Other products represented 3% of revenue in 2025 and are expected to expand at a 4.52% CAGR (2026-2035). Specialty reagent, catalyst-carrier, and quaternary ammonium applications provide a diversified, smaller-scale demand base.
By Application
Silicone Production. Silicone production accounted for 32% of demand in 2025 and is expected to grow at a 4.84% CAGR (2026-2035). Methyl chloride consumption is sustained by chlorosilane production, with higher-value silicone demand increasingly linked to advanced electronics and thermal-management materials.
Refrigerant & Fluorocarbon Feedstock. Refrigerant and fluorocarbon feedstock represented 29% of demand in 2025 and is projected to reach USD 2.03 billion by 2035. The application is being rebalanced from HCFC-22-related chloroform consumption toward feedstock requirements for lower-GWP refrigerants.
Pharmaceutical Processing. Pharmaceutical processing generated USD 630 million in 2025 and is forecast to advance at a 5.24% CAGR (2026-2035). API synthesis, extraction, and specialty reaction routes sustain demand for qualified DCM and chloroform grades despite wider solvent-substitution initiatives.
Agrochemical Synthesis. Agrochemical synthesis represented 7% of demand in 2025 and is projected to reach USD 490 million by 2035. Crop-protection intermediate production supports consumption in Asia Pacific and Latin America, where manufacturing investment is broadening.
Industrial Solvents & Processing. Industrial solvents and processing generated USD 450 million in 2025 and are projected to hold an 8% share by 2035. Regulatory restrictions and water-based substitutions reduce the addressable market in Western applications, while less-regulated industrial uses provide partial support.
Methyl Cellulose & Building Products. Methyl cellulose and building products are projected to reach USD 350 million by 2035 and grow at a 4.52% CAGR (2026-2035). Construction adhesives, drymix mortars, and tile systems provide a steady downstream outlet for methyl chloride-derived materials.
Others. Other applications represented 3% of demand in 2025 and are projected to reach USD 210 million by 2035. Laboratory, catalyst, and specialty intermediate uses add incremental demand without altering the market's primary application structure.
By End-User Industry
Silicone & Polymer Manufacturers. Silicone and polymer manufacturers generated USD 1.35 billion in 2025 and are forecast to grow at a 5.52% CAGR (2026-2035). Their purchasing behavior is shaped by integration with chlorosilane production and by demand from performance-material applications.
Pharmaceutical & Life Sciences. Pharmaceutical and life sciences are projected to reach USD 1.05 billion by 2035 and represented 14% of demand in 2025. Qualification requirements and API manufacturing expansion make this a comparatively defensible end-user channel.
Agrochemical Manufacturers. Agrochemical manufacturers generated USD 315 million in 2025 and are expected to expand at a 4.52% CAGR (2026-2035). Demand follows crop-protection intermediate production and regional agricultural-input manufacturing.
Refrigerant & Fluorocarbon Manufacturers. Refrigerant and fluorocarbon manufacturers generated USD 1.26 billion in 2025 and are projected to hold a 29% share by 2035. Their demand mix increasingly favors next-generation refrigerant feedstock over legacy HCFC-linked volumes.
Construction & Building Materials. Construction and building materials are projected to reach USD 350 million by 2035 and represented 6% of demand in 2025. Methyl-cellulose-based products provide a stable outlet, though project cycles and regional construction economics constrain momentum.
Paints, Coatings & Adhesives. Paints, coatings, and adhesives generated USD 270 million in 2025 and are projected to hold a 3.67% share by 2035. DCM restrictions are structurally reducing the relevance of this end-user group in regulated markets.
Others. Other end-user industries represented 9% of demand in 2025 and are forecast to grow at a 2.38% CAGR (2026-2035). Automotive, personal care, textiles, and electronics processing provide diversified but comparatively fragmented demand.
By Production Process
Methanol Hydrochlorination. Methanol hydrochlorination generated USD 2.83 billion in 2025 and is projected to hold a 65% share by 2035. The route is well aligned with methyl chloride and chlorosilane value chains, favoring integrated operators with downstream silicone exposure.
Methane Chlorination. Methane chlorination represented 32% of production-process demand in 2025 and is projected to reach USD 2.10 billion by 2035. Its ability to generate multiple chlorinated methane products remains valuable where producers require a broad output slate.
Others. Other processes represented 5% of demand in 2025 and are expected to grow at a 4.52% CAGR (2026-2035). Hybrid and emerging routes are relevant where feedstock flexibility or process-efficiency improvements justify investment.
GMI Analyst View
We believe product labels alone obscure the more important strategic distinction: methyl chloride is leveraged to silicone growth, whereas chloroform and carbon tetrachloride are increasingly determined by refrigerant-transition pathways. Competitive positioning will therefore favor suppliers that align product slates with protected, integrated downstream demand.
Chloromethane Market Regional Analysis
Asia Pacific Chloromethane Market Analysis
The chloromethane market in Asia Pacific generated USD 2.11 billion in 2025 and is forecast to expand at a 5.37% CAGR (2026-2035). The region combines large-scale silicone and fluorochemical manufacturing with expanding pharmaceutical and agrochemical production, reinforcing its position as the central demand and production hub.
China. China generated USD 1.26 billion in 2025 and is projected to represent 62.02% of Asia Pacific demand by 2035. Integrated silicone, refrigerant, pharmaceutical, and agrochemical chains create a deep captive and merchant consumption base.
India. India is projected to reach USD 571 million by 2035 and grow at a 6.07% CAGR (2026-2035). Domestic capacity additions and pharmaceutical and agrochemical offtake strengthen the country's role as a high-growth market; GACL reported increased Dahej plant utilization in FY25 [5]Gujarat Alkalies and Chemicals Limited. "Annual Report 2024-25." gacl.com.
Japan. Japan generated USD 212 million in 2025 and is projected to represent 8.99% of Asia Pacific demand by 2035. Mature but high-value pharmaceutical and specialty silicone applications support demand quality.
South Korea. South Korea represented 6.99% of Asia Pacific demand in 2025 and is projected to reach USD 214 million by 2035. Electronics materials and specialty chemical manufacturing underpin its demand profile.
Rest of Asia Pacific. Rest of Asia Pacific represented 7.99% of regional demand in 2025 and is forecast to grow at a 3.97% CAGR (2026-2035). Southeast Asian pharmaceutical, agrochemical, and industrial users provide a broad secondary demand base.
North America Chloromethane Market Analysis
North America represented 24% of chloromethane market demand in 2025 and is projected to reach USD 1.54 billion by 2035. The region retains strength in integrated chlorinated-organics and HFO production, although U.S. DCM restrictions alter the demand profile for solvent applications.
United States. The United States generated USD 972 million in 2025 and is projected to reach USD 1.38 billion by 2035. Pharmaceutical-grade production and HFO feedstock demand partly offset the loss of broad industrial solvent uses.
Canada. Canada represented 10% of North American demand in 2025 and is projected to reach USD 154 million by 2035. Its demand is linked to the wider North American chlorinated-organics supply chain.
Europe Chloromethane Market Analysis
Europe generated USD 810 million in 2025 and is projected to hold a 16% share by 2035. Higher energy costs, stringent compliance obligations, and selective capacity rationalization weaken its production competitiveness while preserving specialized pharmaceutical and chemical demand.
Germany. Germany generated USD 203 million in 2025 and is projected to represent 23.04% of European demand by 2035. Specialty chemical and pharmaceutical applications remain important, but cost conditions challenge domestic production economics.
United Kingdom. The United Kingdom represented 18.02% of European demand in 2025 and is projected to reach USD 190 million by 2035. Pharmaceutical manufacturing and specialty processing support demand despite supply-chain adjustments.
France. France represented 20% of European demand in 2025 and is forecast to grow at a 2.78% CAGR (2026-2035). The Tavaux mothballing highlights the pressure on local chloromethane capacity and shifts supply reliance toward alternative European production.
Rest of Europe. Rest of Europe is projected to reach USD 459 million by 2035 and grow at a 4.37% CAGR (2026-2035). Central and Eastern European pharmaceutical, agrochemical, and construction-material demand provides relative support.
Latin America Chloromethane Market Analysis
Latin America is projected to reach USD 490 million by 2035 and grow at a 4.52% CAGR (2026-2035). Agrochemical manufacturing, pharmaceutical processing, and construction materials underpin regional demand.
Brazil. Brazil generated USD 142 million in 2025 and is projected to reach USD 221 million by 2035. Its diversified industrial base supports agrochemical and pharmaceutical consumption.
Mexico. Mexico is projected to reach USD 172 million by 2035 and grow at a 4.58% CAGR (2026-2035). Proximity to North American supply and expanding specialty chemical manufacturing support demand.
Rest of Latin America. Rest of Latin America represented 20% of regional demand in 2025 and is forecast to grow at a 4.41% CAGR (2026-2035). Agricultural and pharmaceutical manufacturing remain the principal growth channels.
Middle East & Africa Chloromethane Market Analysis
Middle East & Africa represented 4% of chloromethane market demand in 2025 and is projected to reach USD 280 million by 2035. Downstream chemical investment in Gulf markets and pharmaceutical and agricultural applications across Africa provide the region's demand foundation.
Saudi Arabia. Saudi Arabia generated USD 54 million in 2025 and is forecast to grow at a 5.24% CAGR (2026-2035). Petrochemical diversification supports rising specialty chemical consumption.
UAE. The UAE represented 25% of regional demand in 2025 and is projected to reach USD 73 million by 2035. Industrial zones and specialty chemical processing strengthen downstream demand.
South Africa. South Africa represented 15% of regional demand in 2025 and is projected to reach USD 39 million by 2035. Industrial and pharmaceutical applications support demand within a constrained domestic production environment.
Rest of Middle East & Africa. Rest of Middle East & Africa represented 30% of regional demand in 2025 and is projected to hold a 27.86% share by 2035. Agrochemical and pharmaceutical uses remain dispersed across the residual regional market.
GMI Analyst View
We expect Asia Pacific to consolidate its importance because integration across silicone, fluorochemical, pharmaceutical, and agrochemical chains supports both consumption and production investment. Europe faces a more difficult balance: specialty demand persists, but cost-driven capacity rationalization increasingly shifts competitive advantage elsewhere.
Chloromethane Market Share & Competitive Landscape
The chloromethane market share structure is moderately concentrated, with the five largest producers holding a combined 57.30% share in 2025. Competitive advantage rests on chlorine integration, access to low-cost utilities and feedstocks, regulatory qualification, and proximity to downstream silicone, fluorochemical, and pharmaceutical customers.
Olin Corporation held a 14.70% share in 2025. Its integrated chlor-alkali and chlorinated-organics footprint supports a broad product slate, while the company's Freeport capacity actions indicate continued emphasis on disciplined asset optimization [6]Olin Corporation. "Form 8-K: Determination to Permanently Close Chlorine 3 Manufacturing Facility, Freeport TX." sec.gov.
OxyChem held an 11.80% share in 2025. Its North American chlor-alkali integration supports supply to chlorinated-organics and specialty chemical markets, with a cost position shaped by regional feedstock and utility advantages.
Shin-Etsu Chemical held an 11.50% share in 2025. Its integrated chloromethane-to-chlorosilane-to-silicone model strengthens feedstock security and aligns production economics with downstream silicone margins.
INEOS Inovyn remains a significant European supplier, but its Tavaux mothballing illustrates the regional impact of weak demand, energy costs, and regulatory pressures [4]INEOS Inovyn. "INEOS Inovyn Announces the Mothballing of Its Chloromethane Production Facility in Tavaux, France." ineos.com. GACL's Indian position is reinforced by domestic pharmaceutical and agrochemical demand and its announced capacity-development plans [5]Gujarat Alkalies and Chemicals Limited. "Annual Report 2024-25." gacl.com. Chinese producers, including Shandong Dongyue Group and LUXI Chemical Group, add competitive intensity through integration with fluorochemical, silicone, and chlor-alkali operations.
Recent Industry Developments
INEOS Inovyn mothballed its chloromethane facility at Tavaux, France, effective September 2025, citing weak demand, regulatory challenges, and elevated operating costs. The company identified Rosignano, Italy, as the alternative production location for customer supply [4]INEOS Inovyn. "INEOS Inovyn Announces the Mothballing of Its Chloromethane Production Facility in Tavaux, France." ineos.com.
GACL proposed an expansion and modification of chloromethane capacity at Bharuch, Gujarat, during 2025. The proposal remains subject to environmental-clearance processes and reflects the company's response to domestic specialty chemical demand [5]Gujarat Alkalies and Chemicals Limited. "Annual Report 2024-25." gacl.com.
Olin announced the permanent closure of its Chlorine 3 facility in Freeport, Texas, as part of its capacity-optimization program [6]Olin Corporation. "Form 8-K: Determination to Permanently Close Chlorine 3 Manufacturing Facility, Freeport TX." sec.gov.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →